alexa Spectrum of Autoimmune Disorders in Type 1 Diabetes - A Cross-Sectional Clinical Audit | Open Access Journals
ISSN: 2155-6156
Journal of Diabetes & Metabolism
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Spectrum of Autoimmune Disorders in Type 1 Diabetes - A Cross-Sectional Clinical Audit

Barry Joffe, Larry Distiller*, Stanley Landau, Laura Blacking and Anna Klisiewicz

Centre for Diabetes and Endocrinology, 81, Central Street, Houghton, 2198, Johannesburg, South Africa

*Corresponding Author:
Larry Distiller
Centre for Diabetes and Endocrinology
81, Central Street, Houghton
2198, Johannesburg, South Africa
Tel: +27 11712-6000
Fax: +27 11728-9097
E-mail: [email protected]

Received date: November 03, 2010; Accepted date: December 28, 2010; Published date: December 28, 2010

Citation: Joffe B, Distiller L, Landau S, Blacking L, Klisiewicz A (2010) Spectrum of Autoimmune Disorders in Type 1 Diabetes – A Cross-Sectional Clinical Audit. J Diabetes Metab 1:112. doi: 10.4172/2155-6156.1000112

Copyright: © 2010 Joffe B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Diabetes & Metabolism

Keywords

Autoimmune disorders; Type 1 diabetes; Hypothyroidism; Autoimmune polyendocrine syndromes

Introduction

The current estimated prevalence of diabetes worldwide is 285 million people [1], of which 5 – 10% are of the Type 1 variety. Most cases of Type 1 diabetes are thought to have an autoimmune basis, with various environmental factors interacting with an underlying genetic predisposition, leading to selective autoimmune destruction of pancreatic beta cells [2]. In keeping with the autoimmune aetiology, other (organ-specific) autoimmune diseases occur with increased frequency in this situation. These include Addison’s Disease (adrenocorticol failure), Grave’s hyperthyroidism, hypothyroidism, hypogonadism, coeliac disease, pernicious anaemia and vitiligo [3]. The term autoimmune polyendocrine syndromes encompass some of these associations [4].

Few large-scale surveys of the prevalence of these co-existing autoimmune disorders have been reported. Therefore the aim of the present study was to establish their frequency in a large cohort of patients with Type 1 diabetes attending a diabetes clinic in Johannesburg, South Africa.

Patients and Methods

From the Centre for Diabetes and Endocrinology (CDE) in Johannesburg, we randomly surveyed the records of 504 patients with longstanding established Type 1 diabetes. This comprised about 20% of our total Type 1 diabetic database [5]. There were 258 males and 246 female subjects who were of Caucasian descent, except for 6 Asian and 4 African patients. The classification of Type 1 diabetes had been made on clinical grounds. All patients presented at a young age with classical osmotic symptoms and required insulin from the time of diagnosis.

Having pre-selected the autoimmune features to be analyzed, we recorded the number of subjects with a clinical diagnosis of: - hypothyroidism, adrenocorticol insufficiency, pernicious anaemia, celiac disease, vitiligo or a systemic autoimmune disorder. A particular patient may have manifested more than one of these features. Where appropriate, the clinical diagnosis had been confirmed biochemically.

The number of patients manifesting each of these features was tabulated and the female:male distribution calculated. The Chi square test was used to determine significant differences between the sexes, when indicated.

Results

(Table 1) summarises the distribution (number and percentages) of autoimmune features in the 504 patients with Type 1 diabetes included in our survey. Noteworthy was the high prevalence (20.2% overall, 30.9% females and 10.1% males) of documented hypothyroidism in both sexes – but significantly higher in females (p < 0.0002). Other autoimmune disorders were much less common, but again consistently higher in female subjects.

Group Number Hypothyroidism Adrenal Insufficiency Pernicious Anaemia Coeliac Disease Vitiligo Systematic Autoimmune *
Total 504 102 (20.2%) 9 (1.8%) 2 (0.4%) 3 (0.6%) 10 (2%) 8 (1.6%)
Females 246 76  (30.9%) ** 6 (2.4%) 2 (0.8%) 3 (1.2%) 7  (2.8%) 7 (2.8%)
Males 258 26  (10.1%) 3 (1.2%) 0 0 3  (1.2%) 1 (0.4%)

Table 1: Distribution of Auto-Immune features in 504 patients with Type 1 Diabetes attending the CDE. Numbers (%).

Not shown in the table are the inter-relationships of various autoimmune features in individual patients. Six of them had both hypothyroidism plus adrenal insufficiency, 6 patients (all females) had both hypothyroidism and vitiligo while 5 subjects manifested both hypothyroidism and systemic autoimmunity.

Discussion

Our large cross-sectional audit has confirmed the previously described strong association between Type 1 diabetes and autoimmune hypothyroidism constituting the autoimmune polyglandular syndrome Type 3 variant [6,7]. Recent studies have shown a shared genetic susceptibility to both conditions, with most of the shared genes being involved in immune regulation [8]. In particular the CTLA – 4, HLA – class – 11 and FOXP3 genes were implicated. We have shown a somewhat higher prevalence than previous reports involving smaller patient numbers [9]. However, the assumption that all our cases of hypothyroidism were autoimmune in aetiology remains speculative since thyroid autoantibodies (thyroperoxidase and thyroglobulin) were not routinely documented.

The next, but much less frequent, endocrine association in our study was that of adrenocorticol insufficiency; this occurring together with hypothyroidism supports a diagnosis of autoimmune polyglandular syndrome Type 2. An association with HLA – class – 11 genes has also been reported here, suggesting an enhanced susceptibility to certain viral infections [10]. Other, non-endocrine, associations were sporadically encountered, although consistently higher in females.

A number of limitations of the current survey should be mentioned. In common with many clinical audits, we lacked a control group of non-diabetic individuals. Since thyroid disorders are not uncommon in the general population [11], the magnitude of our association between Type 1 diabetes and hypothyroidism may have been over-estimated. More over antibody data were not always available to confirm the autoimmune aetiology, as previously mentioned.

From a practical standpoint, screening for thyroid (and perhaps related) autoimmune disease should become part of the routine investigation of newly diagnosed Type 1 diabetic patients and appropriate replacement therapy instituted at an early stage. According to recent guidelines proposed by the American Diabetes Association [12], this should entail measurement of thyroid autoantibodies at diagnosis and thyroid - stimulating hormone levels every 1 – 2 years if replacement therapy has been instituted.

Acknowledgements

Funding: None

Competing interests: None declared

Ethical approval: Not required

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11762
  • [From(publication date):
    December-2010 - Nov 21, 2017]
  • Breakdown by view type
  • HTML page views : 7987
  • PDF downloads : 3775
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords